Revance Therapeutics DSO Ratio 2011-2026 | RVNC

Annual DSO Ratio Revance Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30.4	20.2	12.1	21.8	55.4 K	10.1 K	123	123	228	250	66.6	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
55.4 K	12.1	6.03 K

Quarterly DSO Ratio Revance Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
64.3	46	50.5	-	34.1	25.4	24.7	-	27.2	16.2	14.1	-	5.31	14.1	24.1	-	31.3	287	1.44 K	2.56 K	31.7 K	-	4.43 K	5.06 K	1.04 K	3.59 K	6.39 K	59.2	-	-	77.9	77.9	-	-	45.6	45.6	-	-	182	1.05 K	979	1.2 K	581	66.4	130	274	137	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
31.7 K	5.31	1.72 K

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Coherus BioSciences CHRS	559	$ 1.57	-3.68 %	$ 184 M	USA
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	70.9	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 7.47	-4.6 %	$ 205 M	Israel
Eton Pharmaceuticals ETON	39.1	$ 30.26	1.0 %	$ 814 M	USA
Exelixis EXEL	43.4	$ 50.13	-1.9 %	$ 13.6 B	USA
Fortress Biotech FBIO	115	$ 2.41	4.78 %	$ 67.2 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	173	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.63	2.52 %	$ 434 M	Britain
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Gilead Sciences GILD	57.8	$ 129.58	-1.88 %	$ 161 B	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Esperion Therapeutics ESPR	99.7	$ 3.12	-	$ 649 M	USA
Genmab A/S GMAB	97.9	$ 26.54	-1.34 %	$ 1.72 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA